Patients with HIV face a significantly higher 30-day readmission risk following hospitalization for HF or AMI compared with those without HIV.
People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus for certain participants in recent trials in Africa and Europe A digital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback